QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
Log in
NYSE:CC

Chemours Stock Forecast, Price & News

$20.21
-0.38 (-1.85 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$20.07
Now: $20.21
$20.83
50-Day Range
$19.25
MA: $20.79
$22.33
52-Week Range
$7.02
Now: $20.21
$22.59
Volume912,335 shs
Average Volume2.56 million shs
Market Capitalization$3.32 billion
P/E RatioN/A
Dividend Yield4.86%
Beta2.46
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Read More
Chemours logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.80 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
CUSIPN/A
Phone302-773-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.53 billion
Cash Flow$4.22 per share
Book Value$4.25 per share

Profitability

Net Income$-52,000,000.00

Miscellaneous

Employees7,000
Market Cap$3.32 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$20.21
-0.38 (-1.85 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chemours (NYSE:CC) Frequently Asked Questions

How has Chemours' stock been impacted by Coronavirus (COVID-19)?

Chemours' stock was trading at $10.66 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CC shares have increased by 89.6% and is now trading at $20.21.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Chemours?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Chemours
.

When is Chemours' next earnings date?

Chemours is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Chemours
.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) released its quarterly earnings data on Thursday, July, 30th. The specialty chemicals company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.09. The specialty chemicals company had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.08 billion. Chemours had a negative net margin of 2.28% and a positive return on equity of 47.31%.
View Chemours' earnings history
.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Wednesday, July 29th. Investors of record on Monday, August 17th will be paid a dividend of $0.25 per share on Tuesday, September 15th. This represents a $1.00 annualized dividend and a yield of 4.95%. The ex-dividend date of this dividend is Friday, August 14th.
View Chemours' dividend history
.

What price target have analysts set for CC?

10 analysts have issued 1 year target prices for Chemours' shares. Their forecasts range from $11.00 to $22.00. On average, they expect Chemours' share price to reach $16.60 in the next year. This suggests that the stock has a possible downside of 17.9%.
View analysts' price targets for Chemours
.

Who are some of Chemours' key competitors?

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), E I Du Pont De Nemours And Co (DD), Pfizer (PFE), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), Energy Transfer LP Unit (ET) and CVS Health (CVS).

Who are Chemours' key executives?

Chemours' management team includes the following people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by many different institutional and retail investors. Top institutional investors include FMR LLC (14.24%), Vanguard Group Inc. (9.60%), Sessa Capital IM L.P. (6.59%), LSV Asset Management (2.51%), Bank of New York Mellon Corp (1.90%) and Two Sigma Advisers LP (0.61%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, David C Shelton, E Bryan Snell, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher.
View institutional ownership trends for Chemours
.

Which major investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Goldman Sachs Group Inc., Partners Capital Investment Group LLP, State of Wisconsin Investment Board, First Trust Advisors LP, DNB Asset Management AS, Holocene Advisors LP, and Canada Pension Plan Investment Board. Company insiders that have sold Chemours company stock in the last year include Edwin C Sparks, and Mark P Vergnano.
View insider buying and selling activity for Chemours
.

Which major investors are buying Chemours stock?

CC stock was bought by a variety of institutional investors in the last quarter, including Sessa Capital IM L.P., Point72 Asset Management L.P., Portolan Capital Management LLC, Brightline Capital Management LLC, Vanguard Group Inc., Advisors Asset Management Inc., Federated Hermes Inc., and Bank of New York Mellon Corp. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown, and Susan M Kelliher.
View insider buying and selling activity for Chemours
.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $20.21.

How big of a company is Chemours?

Chemours has a market capitalization of $3.32 billion and generates $5.53 billion in revenue each year. The specialty chemicals company earns $-52,000,000.00 in net income (profit) each year or $2.51 on an earnings per share basis. Chemours employs 7,000 workers across the globe.

What is Chemours' official website?

The official website for Chemours is www.chemours.com.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.